Zura Bio Limited Class A

Stage 4 · Declining · week 3

As of Oct 22, 2026, Zura Bio is in Stage 4, the downtrend phase, now in week 3 (since Oct 2, 2026). It closed at $3.53, 49.9% below its 52-week high and below its 200-day average, which is falling.

Zura Bio Limited, a clinical-stage biotechnology company, develops medicines for autoimmune and inflammatory disorders in the United States. More about the company

$3.53

-15.28% today

$338M · Small cap

Market Neutral — Building

Pro read

Pro

Our read

Declining, below its long-term trend

Setup score

—

Momentum

Steady

Edge

—

Is ZURA early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…

Stage Cycle Timeline2023-08-16 → 2026-10-22

S? 20w

S4 18w

S4 32w

S2 32w

2023-08-162026-10-22

S1S2S3S4Setup score (0–10, dashed line at 5)

S? 20w → S4 18w → S1 7w → S2 3w → S3 2w → S4 6w → S1 4w → S2 7w → S3 2w → S4 32w → S1 7w → S2 32w → S3 8w → S4 5w → S1 4w → S2 6w → S3 1w → S4 3w current

Total tracked: 166 weeks across 18 stage runs.

ZURA among Biotechnology175th of 591 by relative strength

All 591 →

Stocks in Biotechnology ranked by relative strength, with stage and one-month change
#	Stock	Stage	RS	1M
1	GTBPGT Biopharma, Inc.	Stage 2 · wk 7	99	−22.3%
2	IOVAIovance Biotherapeutics, Inc.	Stage 2 · wk 18	99	+38.8%
3	SLSSELLAS Life Sciences Group, Inc.	Stage 3 · wk 4	99	−1.5%
4	MRNAModerna, Inc.	Stage 2 · wk 17	99	+11.3%
5	TWSTTwist Bioscience Corporation	Stage 2 · wk 39	99	−14.5%
6	KODKodiak Sciences Inc	Stage 2 · wk 4	99	+172.1%
7	ERASErasca, Inc.	Stage 3 · wk 5	99	+0.7%
8	CLYMClimb Bio, Inc.	Stage 3 · wk 3	99	−15.8%
…175	ZURAZura Bio Limited Class A	Stage 4 · wk 3	58	−18.5%

vs 52W High

-49.9%

$3.33 lo$7.04 hi

49.9% below 52W high, deep Stage 4 damage

In Stage 4, distance from the 52-week high reflects an ongoing decline, not a discount.

Stage Maturity

Week 3

1w13w26w

Week 3, early Stage 4 decline

How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure. No length of decline marks a bottom on its own.

vs 200 DMA

-33.1%

200 DMA: $5.28 · sloping down

In Stage 4, the stock is below its 200-day average, the hallmark of a downtrend. Stage analysis waits for that to reverse before buying.

Rel Volume

3.36x

vs 50-day avg

High volume on down days in Stage 4 confirms institutional selling. Low-volume bounces are typical. They lack real buyers and are easy to mistake for reversals.

Trend Health

↓

Short-term trend rolling over

Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.

-18.5%

-32.5%

-36.1%

YTD

-36.4%

+3.8%

Scan Membership

Breakout Watch

Latest: 2024-10-11

2 appearances in last 60 days. First seen: 2024-06-28.

A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.

Recent Stage Timeline

2026-10-22S4

Wk 3 · Vol 3.36x

2026-10-21S4

Wk 3 · Vol 1.56x

2026-10-20S4

Wk 3 · Vol 1.32x

2026-10-19S4

Wk 3 · Vol 1.86x

2026-10-16S4

Wk 3 · Vol 2.08x

2026-10-15S4

Wk 2 · Vol 2.19x

2026-10-14S4

Wk 2 · Vol 2.64x

2026-10-13S4

Wk 2 · Vol 14.41x

2026-10-12S4

Wk 2 · Vol 0.96x

2026-10-09S4

Wk 2 · Vol 1.04x

2026-10-08S4

Wk 1 · Vol 1.68x

2026-10-07S4

Wk 1 · Vol 1.33x

Moving averages & range

50 DMA

$4.88

200 DMA

$5.28

52W High

$7.04

52W Low

$3.33

5D Low

$3.53

Resistance levels (recent highs)

20d High

$4.41

60d High

$6.32

120d High

$6.32

250d High

$7.04

Next resistance

+24.9%

to 20d High

ROE

-51.0%

Profit margin 0.0%

Dividend Yield

0.00%

P/B 1.7

Zura Bio: quick answers

What stage is Zura Bio in?

As of Oct 22, 2026, Zura Bio (ZURA) is in Stage 4, the downtrend phase. It entered Stage 4 on Oct 2, 2026 and is in week 3. What the four stages mean

Is Zura Bio in an uptrend?

No. Zura Bio is in a Stage 4 downtrend. It trades 33.1% below its 200-day average, which is falling.

How far is Zura Bio from its 52-week high?

Zura Bio closed at $3.53 on Oct 22, 2026, 49.9% below its 52-week high of $7.04. Its 52-week low is $3.33.

How has Zura Bio performed over the past year?

As of Oct 22, 2026, Zura Bio is up 3.8% over the past year and down 36.4% so far in 2026.

Which sector and industry is Zura Bio in?

Zura Bio is in the Biotechnology industry, part of the Health Care sector.

About this companyHealth Care· Biotechnology

Zura Bio Limited, a clinical-stage biotechnology company, develops medicines for autoimmune and inflammatory disorders in the United States. The company develops Tibulizumab, a humanized IgG4 single-chain variable fragment bispecific antibody engineered to bind and neutralize both IL-17A and BAFF within a single therapeutic molecule, which is in Phase 2 clinical trial development. It also develops Torudokimab (ZB-880), a fully human immunoglobulin G4 monoclonal antibody targeting interleukin-33 that has completed Phase 1 clinical studies; and Crebankitug (ZB-168), a fully human immunoglobulin G1 monoclonal antibody targeting interleukin-7 receptor alpha that has completed Phase 1 clinical studies. Zura Bio Limited was founded in 2022 and is headquartered in Henderson, Nevada.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.